Wall Street analysts forecast that II-VI, Inc. (NASDAQ:IIVI) will announce sales of $339.22 million for the current quarter, Zacks reports. Five analysts have issued estimates for II-VI’s earnings. The highest sales estimate is $340.00 million and the lowest is $338.60 million. II-VI reported sales of $281.47 million in the same quarter last year, which would suggest a positive year over year growth rate of 20.5%. The business is scheduled to announce its next quarterly earnings report on Thursday, February 7th.

On average, analysts expect that II-VI will report full-year sales of $1.34 billion for the current fiscal year, with estimates ranging from $1.30 billion to $1.37 billion. For the next year, analysts forecast that the firm will report sales of $1.50 billion, with estimates ranging from $1.42 billion to $1.60 billion. Zacks Investment Research’s sales calculations are a mean average based on a survey of sell-side analysts that cover II-VI.

II-VI (NASDAQ:IIVI) last posted its quarterly earnings data on Thursday, November 1st. The scientific and technical instruments company reported $0.56 EPS for the quarter, hitting the consensus estimate of $0.56. The firm had revenue of $314.40 million during the quarter, compared to analyst estimates of $310.92 million. II-VI had a net margin of 7.68% and a return on equity of 10.89%. II-VI’s revenue was up 20.2% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.32 EPS.

Several research analysts recently commented on the stock. B. Riley lowered shares of II-VI from a “buy” rating to a “neutral” rating and set a $54.00 price objective for the company. in a research note on Tuesday, September 4th. Deutsche Bank assumed coverage on shares of II-VI in a research note on Monday, August 27th. They set a “buy” rating and a $58.00 price objective for the company. BidaskClub upgraded shares of II-VI from a “sell” rating to a “hold” rating in a research note on Thursday, August 23rd. Morgan Stanley set a $48.00 price objective on shares of II-VI and gave the stock a “hold” rating in a research note on Wednesday, August 8th. Finally, Cowen reiterated a “buy” rating and set a $64.00 price objective on shares of II-VI in a research note on Wednesday, August 8th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and nine have issued a buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus target price of $53.69.

Shares of NASDAQ IIVI traded down $8.87 during trading hours on Wednesday, hitting $38.01. 6,126,478 shares of the stock were exchanged, compared to its average volume of 736,262. The company has a quick ratio of 2.45, a current ratio of 3.63 and a debt-to-equity ratio of 0.50. The firm has a market cap of $2.95 billion, a PE ratio of 22.10, a price-to-earnings-growth ratio of 1.51 and a beta of 0.66. II-VI has a 12 month low of $34.88 and a 12 month high of $53.08.

In other II-VI news, Director Marc Y. E. Pelaez sold 4,485 shares of the company’s stock in a transaction that occurred on Thursday, August 16th. The shares were sold at an average price of $45.40, for a total transaction of $203,619.00. Following the transaction, the director now owns 61,149 shares in the company, valued at approximately $2,776,164.60. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, VP David G. Wagner sold 4,833 shares of the company’s stock in a transaction that occurred on Tuesday, September 25th. The shares were sold at an average price of $49.00, for a total transaction of $236,817.00. Following the transaction, the vice president now owns 65,211 shares in the company, valued at approximately $3,195,339. The disclosure for this sale can be found here. Insiders have sold a total of 43,504 shares of company stock worth $2,083,715 in the last 90 days. 4.00% of the stock is currently owned by company insiders.

A number of institutional investors have recently modified their holdings of IIVI. Russell Investments Group Ltd. increased its stake in II-VI by 6.6% during the 1st quarter. Russell Investments Group Ltd. now owns 19,129 shares of the scientific and technical instruments company’s stock valued at $782,000 after purchasing an additional 1,185 shares in the last quarter. Thompson Investment Management Inc. acquired a new stake in shares of II-VI in the second quarter worth $408,000. Amalgamated Bank increased its stake in shares of II-VI by 17.2% in the second quarter. Amalgamated Bank now owns 9,995 shares of the scientific and technical instruments company’s stock worth $434,000 after acquiring an additional 1,470 shares during the period. Janney Capital Management LLC increased its stake in shares of II-VI by 6.4% in the second quarter. Janney Capital Management LLC now owns 24,564 shares of the scientific and technical instruments company’s stock worth $1,067,000 after acquiring an additional 1,481 shares during the period. Finally, Alps Advisors Inc. acquired a new stake in shares of II-VI in the second quarter worth $579,000. Institutional investors and hedge funds own 92.59% of the company’s stock.

About II-VI

II-VI Incorporated develops, manufactures, and markets engineered materials, and optoelectronic components and devices worldwide. The company operates in three segments: II-VI Laser Solutions, II-VI Photonics, and II-VI Performance Products. The II-VI Laser Solutions segment offers optical and electro-optical components and materials primarily used in high-power CO2 lasers; fiber-delivered beam delivery systems, and processing tools and direct diode lasers for industrial lasers; direct diode laser modules, sub-systems, and systems; super-hard materials processing laser systems; and compound semiconductor epitaxial and gallium arsenide wafers.

Featured Story: How to calculate compound interest

Get a free copy of the Zacks research report on II-VI (IIVI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for II-VI (NASDAQ:IIVI)

Receive News & Ratings for II-VI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for II-VI and related companies with MarketBeat.com's FREE daily email newsletter.